SELLAS Life Sciences nears Phase 3 trigger; shares +7%
SELLAS Life Sciences (SLS) shares rose 7% as the company approaches a trigger for its Phase 3 trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.